Active Ingredient: LAMIVUDINE; RALTEGRAVIR POTASSIUM
Proprietary Name: DUTREBIS
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG;EQ 300MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N206510
Product Number: 001
Approval Date: Feb 6, 2015
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information
